Xiangxue PharmaceuticalLtd Dividends and Buybacks
Dividend criteria checks 0/6
Xiangxue PharmaceuticalLtd does not currently pay a dividend.
Key information
0%
Dividend yield
0.003%
Buyback Yield
| Total Shareholder Yield | 0.003% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.046 |
| Payout ratio | 0% |
Recent dividend and buyback updates
No updates
Recent updates
Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Held Back By Insufficient Growth Even After Shares Climb 36%
Oct 15
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Shares Bounce 25% But Its Business Still Trails The Industry
Jul 31Benign Growth For Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Underpins Stock's 29% Plummet
Jun 07Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Price Is Right But Growth Is Lacking After Shares Rocket 38%
Mar 12Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 300147's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 300147's dividend payments have been increasing.
Dividend Yield vs Market
| Xiangxue PharmaceuticalLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300147) | 0% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast (300147) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate 300147's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 300147's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: 300147 is not paying a notable dividend for the CN market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 300147 has not reported any payouts.